Temozolomide significantly enhances H3K27ac levels at the enhancer of interleukin-8 (IL-8) locus to promote its expression, which in turn IL-8 promotes the acquisition of stem cell properties such as self-renewal and chemoresistance of glioma cells [14]. The gene discussed is CXCL8; the disease is central nervous system cancer.